Pacific Biosciences of California Competitors and Similar CompaniesClear all
Pacific Biosciences of California's competitors and similar companies include Personalis, Roche, QIAGEN, Thermo Fisher Scientific, BGI Genomics, Illumina and Oxford Nanopore Technologies.
 Pacific Biosciences of California Pacific Biosciences of California (PacBio, formerly known as Nanofluidics) is a company developing a platform for genetic analysis. |  Thermo Fisher Scientific Thermo Fisher Scientific is a company specializing in laboratory equipment, analytical instruments, reagents, consumables, and related technologies for scientific research and applied testing. |  BGI Genomics BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services. |  Illumina Illumina is a company that develops, manufactures, and markets life science tools and sequencing and array-based integrated systems for genetic and genomic analysis. |  Oxford Nanopore Technologies Oxford Nanopore Technologies is a company that develops nanopore-based electronic systems for the analysis of single molecules. | ||||
Founding Date | Founding Date 2004 | Founding Date 2011 | Founding Date 1896 | Founding Date 1984 | Founding Date 1956 | Founding Date 1999 | Founding Date 1998 | Founding Date 2005 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||||
Locations | Locations Menlo Park, US HQ Shanghai, CN Yokohama, JP Seoul, KR Singapore, SG London, GB Baltimore, US see more | Locations Fremont, US HQ West Wickham, GB | Locations Venlo, NL HQ Clayton, AU São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN Shanghai, CN see more | Locations Waltham, US HQ Buenos Aires, AR Buenos Aires, AR Buenos Aires, AR Adelaide Airport, AU Brendale, AU Canberra, AU see more | Locations Shenzhen, CN HQ Brisbane, AU Copenhagen, DK Addis Ababa, ET Hong Kong, HK Budapest, HU Kobe, JP see more | Locations San Diego, US HQ Melbourne, AU Wien, AT Mechelen, BE Sao Paulo, BR Vancouver, CA Beijing, CN see more | ||
Employees | Employees 48516% decrease | Employees 22344% decrease | Employees 103,249 | Employees 5,6541% decrease | Employees 125,000 | Employees 3,702 | Employees 8,6004% decrease | Employees 1,382 |
Valuation ($) | Valuation ($) 561.4 m | Valuation ($) 340.9 m | Valuation ($) N/A | Valuation ($) 9.3 b | Valuation ($) 209.2 b | Valuation ($) 2.7 b | Valuation ($) 23.3 b | Valuation ($) 1.8 b |
Financial | ||||||||
Revenue (est.) | Revenue (est.) $160m (FY, 2025) | Revenue (est.) $69.6m (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) $2.1b (FY, 2025) | Revenue (est.) $44.6b (FY, 2025) | Revenue (est.) ¥3.7b (FY, 2025) | Revenue (est.) $4.3b (FY, 2025) | Revenue (est.) £223.9m (FY, 2025) |
Cost of goods | Cost of goods $114.2m (FY, 2025) | Cost of goods $53.9m (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods $577.3m (FY, 2025) | Cost of goods $26.3b (FY, 2025) | Cost of goods ¥2.3b (FY, 2025) | Cost of goods $1.5b (FY, 2025) | Cost of goods £42.8m (FY, 2025) |
Gross profit | Gross profit $45.8m (FY, 2025) | Gross profit $15.8m (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit $1.5b (FY, 2025) | Gross profit $18.2b (FY, 2025) | Gross profit ¥1.4b (FY, 2025) | Gross profit $2.9b (FY, 2025) | Gross profit £181.1m (FY, 2025) |
Net income | Net income ($546.4m) (FY, 2025) | Net income ($81.3m) (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income $437m (FY, 2025) | Net income $6.7b (FY, 2025) | Net income (¥637.8m) (FY, 2025) | Net income $850m (FY, 2025) | Net income (£145.2m) (FY, 2025) |
Operating ⚠ | ||||||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries N/A | Countries 70 (FY, 2023) | Countries 100 (FY, 2022) | Countries N/A | Countries 120 (FY, 2021) |
Remaining Performance Obligations | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations $72m (FY, 2024) | Remaining Performance Obligations $25.3b (Q3, 2024) | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A | Remaining Performance Obligations N/A |
Funding | ||||||||
Total funding raised | Total funding raised $ 681.9m | Total funding raised $ 75m | Total funding raised $ 7.8b | Total funding raised $ 4m | Total funding raised $ 500m | Total funding raised N/A | Total funding raised $ 28m | Total funding raised $ 1.3b |
For sources of this data, please see the company profile
View Company Profiles
Personalis
HQ
Fremont, US
Employees
223↓ 44% decrease
Personalis is a biotechnology company that specializes in cancer genomics.
View company
Roche
HQ
Basel, CH
Employees
103,249
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company
QIAGEN
HQ
Venlo, NL
Employees
5,654↓ 1% decrease
QIAGEN is a company that provides sample technology solutions.
View companyThermo Fisher Scientific
HQ
Waltham, US
Employees
125,000
Thermo Fisher Scientific is a company specializing in laboratory equipment, analytical instruments, reagents, consumables, and related technologies for scientific research and applied testing.
View company